How have user fees affected the FDA? : The 1992 FDA reform successfully reduced drug review times
Year of publication: |
2002
|
---|---|
Authors: | Olson, Mary K. |
Published in: |
Regulation : the Cato review of business and government. - Washington, DC : AEI, ISSN 0147-0590, ZDB-ID 440777-5. - Vol. 25.2002, 1, p. 20-25
|
Subject: | Arzneimittel | Pharmaceuticals | Genehmigung | Permit | Öffentliche Verwaltung | Public administration | Gebühr | Charges | USA | United States |
-
At what price vanity? : an econometric model of the demand for personalized license plates
Alper, Neil O., (1987)
-
Assessing the impacts of the Prescription Drug User Fee Acts (PDUFA) on the FDA approval process
Berndt, Ernst R., (2004)
-
The signaling effects of the US food and drug administration fast-track designation
Miller, Kathleen L., (2017)
- More ...
-
Olson, Mary K., (2020)
-
Pharmaceutical expenditure and regulatory policy in the NHS
Olson, Mary K., (1992)
-
Regulatory agency discretion among competing industries : inside the FDA
Olson, Mary K., (1993)
- More ...